Positional changes of pericentromeric heterochromatin and nucleoli in postmitotic Purkinje cells during murine cerebellum development (original) (raw)
Article navigation
Research Articles| July 14 2004
aDepartment of Biology II, Human Genetics, Ludwig Maximilians University (LMU), Munich;
Search for other works by this author on:
aDepartment of Biology II, Human Genetics, Ludwig Maximilians University (LMU), Munich;
Search for other works by this author on:
bDepartment of Neuropathology, Neurocentre, University of Freiburg, Freiburg (Germany)
Search for other works by this author on:
bDepartment of Neuropathology, Neurocentre, University of Freiburg, Freiburg (Germany)
Search for other works by this author on:
aDepartment of Biology II, Human Genetics, Ludwig Maximilians University (LMU), Munich;
Search for other works by this author on:
Cytogenet Genome Res (2004) 105 (2-4): 302–310.
Received:
October 14 2003
Accepted:
December 15 2003
Published Online:
July 14 2004
Abstract
Previous studies revealed changes of pericentromeric heterochromatin arrangements in postmitotic Purkinje cells (PCs) during postnatal development in the mouse cerebellum (Manuelidis, 1985; Martou and De Boni, 2000). Here, we performed vibratome sections of mouse cerebellum (vermis) at P0 (day of birth), at various stages of the postnatal development (P2–P21), as well as in very young (P28) and 17-months-old adults. FISH was carried out on these sections with major mouse satellite DNA in combination with immunostaining of the nucleolar protein B23 (nucleophosmin). Laser confocal microscopy, 3D reconstructions and quantitative image analysis were employed to describe changes in the number and topology of chromocenters and nucleoli. At all stages of postnatal PC development heterochromatin clusters were typically associated either with nucleoli or with the nuclear periphery, while non-associated clusters were rare (<1% at P0 to P21 and about 3% in adult stages). At P0, about 2–4 nucleoli and 7–8 pericentromeric heterochromatin clusters were variably located within PC nuclei. The relative volume of heterochromatin clusters associated with the nucleoli (about 50%) was roughly equal to the volume of clusters associated with the nuclear periphery. Positional changes of both nucleoli and centromeres towards the nuclear center occurred between P0 and P6. At P6 the average number of chromocenters per PC nucleus had decreased to about five. In agreement with previous studies, one or occasionally two nucleoli were noted at the nuclear center surrounded by major perinucleolar heterochromatin clusters. The relative volume of these perinucleolar clusters increased to about 84%, while the volume of clusters in the nuclear periphery decreased to about 15%. At subsequent postnatal stages, the arrangement of most pericentromeric heterochromatin around a central nucleolus was maintained. In adult animals, however, we observed a partial redistribution of heterochromatin towards the nuclear periphery. The average total number of pericentromeric heterochromatin signals increased again to about ten. The volume of heterochromatin associated with the nuclear periphery roughly doubled (30%), while the volume of the perinucleolar heterochromatin decreased correspondingly.
References
Cremer M, von Hase J, Volm T, Brero A, Kreth G, Walter J, Fischer C, Solovei I, Cremer C, Cremer T: Non-random radial higher-order chromatin arrangements in nuclei of diploid human cells. Chromosome Res 9:541–567 (2001).
Fenili D, De Boni U: Organotypic slices in vitro: repeated, same-cell, high-resolution tracking of nuclear and cytoplasmic fluorescent signals in live, transfected cerebellar neurons by confocal microscopy. Brain Res Brain Res Protoc 11:101–110 (2003).
Hendelman WJ, Aggerwal AS: The Purkinje neuron. I. A Golgi study of its development in the mouse and in culture. J Comp Neurol 193:1063–1079 (1980).
Lafarga M, Andres MA, Fernandez-Viadero C, Villegas J, Berciano MT: Number of nucleoli and coiled bodies and distribution of fibrillar centres in differentiating Purkinje neurons of chick and rat cerebellum. Anat Embryol 191:359–367 (1995).
Legrand C, Thomasset M, Parkes CO, Clavel MC, Rabie A: Calcium-binding protein in the developing rat cerebellum. An immunocytochemical study. Cell Tissue Res 233:389–402 (1983).
Lentz RD, Lapham LW: Postnatal development of tetraploid DNA content in rat Purkinje cells: a quantitative cytochemical study. J Neuropathol Exp Neurol 29:43–56 (1970).
Manuelidis L: Different central nervous system cell types display distinct and nonrandom arrangements of satellite DNA sequences. Proc Natl Acad Sci USA 81:3123–3127 (1984a).
Manuelidis L: Active nucleolus organizers are precisely positioned in adult central nervous system cells but not in neuroectodermal tumor cells. J Neuropathol Exp Neurol 43:225–241 (1984b).
Manuelidis L: Indications of centromere movement during interphase and differentiation. Ann NY Acad Sci 450:205–221 (1985).
Martou G, De Boni U: Nuclear topology of murine, cerebellar Purkinje neurons: changes as a function of development. Exp Cell Res 256:131–139 (2000).
Martou G, Park PC, De Boni U: Intranuclear relocation of the Plc beta3 sequence in cerebellar Purkinje neurons: temporal association with de novo expression during development. Chromosoma 110:542–549 (2002).
Nordquist DT, Kozak CA, Orr HT: cDNA cloning and characterization of three genes uniquely expressed in cerebellum by Purkinje neurons. J Neurosci 8:4780–4789 (1988).
Tsukamoto T, Hashiguchi N, Janicki SM, Tumbar T, Belmont AS, Spector DL: Visualization of gene activity in living cells. Nat Cell Biol 2:871–878 (2000).
Tumbar T, Belmont AS: Interphase movements of a DNA chromosome region modulated by VP16 transcriptional activator. Nat Cell Biol 3:134–139 (2001).
Van Driel R, Fransz PF, Verschure PJ: The eukaryotic genome: a system regulated at different hierarchical levels. J Cell Sci 116:4067–4075 (2003).
Weiss GM, Pysh JJ: Evidence of loss of Purkinje cell dendrites during late development: a morphometric Golgi analysis in the mouse. Brain Res 154:219–230 (1978).
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 